fli1 antibody, Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity

Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity

Ewing sarcoma (EWS), a highly aggressive pediatric tumor, is driven by EWS-FLI1, an oncogenic transcription factor that remodels the tumor genetic landscape. Epigenetic mechanisms play a pivotal role in EWS pathogenesis, and the therapeutic value of compounds targeting epigenetic pathways is being identified in preclinical models. Here we showed that modulation of CD99, a cell…

Read More
Human genetic basis of coronavirus disease 2019

Human genetic basis of coronavirus disease 2019

Coronavirus illness 2019 (COVID-19) attributable to a novel coronavirus, extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in appreciable morbidity and mortality worldwide. COVID-19 incidence, severity, and mortality charges differ tremendously between populations, genders, ABO blood teams, human leukocyte antigen (HLA) genotypes, ethnic teams, and geographic backgrounds. This extremely heterogeneous SARS-CoV-2 an infection is…

Read More